Back to Cresset Asset Management, LLC Cresset Asset Management, LLC

STLNSTLN

Showing 2 of 3 quarters

Position history for Cresset Asset Management, LLCCresset Asset Management, LLC's holdings in Starling Oncology, Inc.

No. Cresset Asset Management exited its STLN (Starling Oncology) position in Q4 2024. Its Q3 2024 13F listed 18,300 shares worth $5,982. Cresset Asset Management first reported STLN in Q2 2024 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$5,982

Total Shares Change

-18,300

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.31
0
2024-Q3
Unchanged
18,300
0.0%
$5,9820.0%$0.33
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used